medicrea
-
Financial
Medicrea Announces $30 Million Senior Secured Notes Issue and a Warrants Issue wholly subscribed by Perceptive Advisors
November 27, 2018 LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea Group (Euronext Growth Paris: FR0004178572- ALMED ; OTCQX Best Market…
Read More » -
Spine
MEDICREA® Achieves 3,000 Surgery Milestone with UNiD ASI™ and Patient Specific Implants
November 20, 2018 LYON, France & NEW YORK–(BUSINESS WIRE)–The MEDICREA® Group (Euronext Growth Paris: FR0004178572-ALMED ; OTCQX Best Market –…
Read More » -
Spine
Medicrea to Attend the 9th Annual Craig-Hallum Alpha Select Conference
November 05, 2018 LYON & NEW YORK–(BUSINESS WIRE)–The Medicrea Group (Euronext Growth Paris: FR0004178572-ALMED ; OTCQX Best Market – MRNTY…
Read More » -
Financial
Medicrea Third Quarter 2018 Sales
October 11, 2018 LYON, France and NEW YORK–(BUSINESS WIRE)–The Medicrea Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best…
Read More » -
Financial
Medicrea Reports First Half 2018 Results
September 19, 2018 LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea Group (Euronext Growth Paris: FR0004178572 – ALMED, PEA-PME eligible, and…
Read More » -
Financial
Medicrea to Begin Trading on the OTCQX Market in the U.S.
August 27, 2018 LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea Group (Euronext Growth Paris: FR0004178572 – ALMED), pioneering the transformation…
Read More » -
Spine
Medicrea Partners with Leading National Spine Distributor to Launch Australian Subsidiary
July 10, 2018 LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea® Group (Euronext Growth Paris: FR0004178572 – ALMED), pioneering the convergence of…
Read More » -
Financial
Medicrea Announces Record Sales for the First Half of 2018
July 05, 2018 LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea Group (Euronext Growth Paris: FR0004178572 -ALMED), pioneering the convergence of…
Read More » -
Hospitals
Medicrea Receives World’s First and Only FDA-Clearance to Market Patient-Specific Cages
May 31, 2018 LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea® Group (Euronext Growth Paris: FR0004178572 – ALMED), pioneering the convergence of…
Read More » -
Financial
Medicrea Publishes 2017 Full Year Results and First Quarter 2018 Sales
April 05, 2018 LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea® Group (Euronext Growth Paris: FR0004178572 – ALMED), pioneering the convergence of…
Read More » -
Spine
Medicrea Partners with Key Distributor to Form Joint Venture in Belgium
March 29, 2018 LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea® Group (Euronext Growth Paris: FR0004178572 – ALMED), pioneering the convergence of…
Read More » -
Spine
Medicrea to Participate in the Canaccord Genuity Musculoskeletal Conference and Present Clinical Results at AAOS 2018
March 05, 2018 LYON, France & NEW YORK–(BUSINESS WIRE)–The Medicrea Group (Euronext Growth Paris: FR0004178572 – ALMED), pioneering the convergence…
Read More » -
Spine
Medicrea Reports Directors’ Dealings Disclosure
February 16, 2018 LYON, France & NEW YORK–(BUSINESS WIRE)–The MEDICREA Group (Euronext Growth: FR0004178572 – ALMED), pioneering the convergence of…
Read More » -
Financial
Medicrea Reports Directors’ Dealings Disclosure
January 30, 2018 LYON, France & NEW YORK–(BUSINESS WIRE)–The MEDICREA Group (Euronext Growth: FR0004178572 – ALMED), pioneering the convergence of…
Read More » -
Financial
Medicrea Reports Full Year 2017 Sales
January 15, 2018 LYON, France & New York–(BUSINESS WIRE)–The MEDICREA Group (Euronext Growth: FR0004178572 – ALMED), pioneering the convergence of…
Read More »